Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema

dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema (clinicaltrials.gov) - Oct 4, 2021 - P2/3; N=482; Not yet recruiting; Sponsor: Oculis
Clinical • New P2/3 trial • Diabetic Macular Edema • Ophthalmology

http://clinicaltrials.gov/ct2/show/NCT05066997

Oct 4, 2021